肠道微生物群的饮食指数与美国成年人的便秘之间的关联
Chunyan Song1, Zhulin Zhang1, Shanxiang Zhu1
1Department of Clinical Laboratory, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Nutrition journal
|July 2, 2025
概括
一个更健康的肠道微生物群,通过更高的肠道微生物群 (DI-GM) 饮食指数来表明,与更低的便秘风险有关. 饮食改变可能有助于预防这种常见的胃肠道问题.
科学领域:
- 胃肠病学 胃肠病学
- 营养科学 营养科学
- 微生物组研究 微生物组研究
背景情况:
- 便秘是一种普遍的胃肠道疾病,影响生活质量.
- 饮食因素和肠道微生物群在便秘的发展中得到越来越多的认可.
- 肠道微生物群的饮食指数 (DI-GM) 衡量了饮食对肠道微生物群多样性的影响.
研究的目的:
- 调查肠道微生物群的饮食指数 (DI-GM) 与便秘患病率之间的关联.
- 为了分析这种关系,使用来自大量美国人口样本的数据.
主要方法:
- 利用国家健康和营养检查调查 (NHANES) 数据 (2005-2010) 来自11,819名参与者.
- 使用布里斯托尔便形式尺度类型1和2来定义便秘.
- 使用多变量加权后勤回归和受限立方线 (RCS) 进行关联分析.
主要成果:
- 较高的DI-GM得分,意味着更健康的肠道微生物群,与便秘风险降低相关.
- 一个更健康的肠道微生物组概况与便秘患病率降低有关.
- 通过RCS分析确定了DI-GM得分和便秘之间的非线性关联.
结论:
- 促进更健康的肠道微生物群的饮食调整可能是预防便秘的可行策略.
- 研究结果表明,饮食,肠道微生物群和便秘风险之间存在重要联系.
- 这项研究强调了理解饮食肠道微生物群指数与便秘有关的公共卫生的重要性.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Assessment of the Rectum and Anus
415
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
415
Drugs for Treatment of Constipation-Predominant IBS
351
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
351
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
255
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
255
Irritable Bowel Syndrome I: Introduction
399
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
399
Chronic Bowel Disorders: Introduction
542
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
542


